Search Results - "Dave Sharp, Zelton"

Refine Results
  1. 1

    Acarbose improved survival for Apc+/Min mice by Dodds, Sherry G., Parihar, Manish, Javors, Martin, Nie, Jia, Musi, Nicolas, Dave Sharp, Zelton, Hasty, Paul

    Published in Aging cell (01-02-2020)
    “…Acarbose blocks the digestion of complex carbohydrates, and the NIA Intervention Testing Program (ITP) found that it improved survival when fed to mice. Yet,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Rapamycin fed late in life extends lifespan in genetically heterogeneous mice by Nelson, James F, Carter, Christy S, Pahor, Marco, Frenkel, Krystyna, Miller, Richard A, Nadon, Nancy L, Wilkinson, J. Erby, Fernandez, Elizabeth, Javors, Martin A, Flurkey, Kevin, Astle, Clinton M, Sharp, Zelton Dave, Harrison, David E, Strong, Randy

    Published in Nature (London) (16-07-2009)
    “…Inhibition of the TOR signalling pathway by genetic or pharmacological intervention extends lifespan in invertebrates, including yeast, nematodes and…”
    Get full text
    Journal Article
  5. 5

    Activation of estrogen receptor-alpha by E2 or EGF induces temporally distinct patterns of large-scale chromatin modification and mRNA transcription by Berno, Valeria, Amazit, Larbi, Hinojos, Cruz, Zhong, Jeannie, Mancini, Maureen G, Sharp, Zelton Dave, Mancini, Michael A

    Published in PloS one (28-05-2008)
    “…Estrogen receptor-alpha (ER) transcription function is regulated in a ligand-dependent (e.g., estradiol, E2) or ligand-independent (e.g., growth factors)…”
    Get full text
    Journal Article
  6. 6

    eRapa Restores a Normal Life Span in a FAP Mouse Model by HASTY, Paul, LIVI, Carolina B, LISHI SUN, HUREZ, Vincent, CURIEL, Tyler J, ZELTON DAVE SHARP, DODDS, Sherry G, JONES, Diane, STRONG, Randy, JAVORS, Martin, FISCHER, Kathleen E, SLOANE, Lauren, MURTHY, Kruthi, HUBBARD, Gene

    “…Mutation of a single copy of the adenomatous polyposis coli (APC) gene results in familial adenomatous polyposis (FAP), which confers an extremely high risk…”
    Get full text
    Journal Article
  7. 7

    Evidence for Down-Regulation of Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR)-Dependent Translation Regulatory Signaling Pathways in Ames Dwarf Mice by Sharp, Zelton Dave, Bartke, Andrzej

    “…How growth hormone (GH) stimulates protein synthesis is unknown. Phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathways…”
    Get full text
    Journal Article
  8. 8

    mTOR inhibitors for treatment of low-risk prostate cancer by Liss, Michael A., Rickborn, Lanette, DiGiovanni, John, Bacich, Dean, DeGraffenried, Linda A., Parihar, Manish, Thompson, Ian M., Sharp, Zelton Dave

    Published in Medical hypotheses (01-08-2018)
    “…Prostate cancer incidence increases with age; along with many other cancers, it could be considered a disease of aging. Prostate cancer screening has led to a…”
    Get full text
    Journal Article
  9. 9

    Aging and cancer: can mTOR inhibitors kill two birds with one drug? by Sharp, Zelton Dave, Richardson, Arlan

    Published in Targeted oncology (01-03-2011)
    “…The main risk factor for a number of diseases, including cancer, is aging. By delaying the effects of aging, many years of research indicate that diseases…”
    Get full text
    Journal Article
  10. 10

    Adaptations to chronic rapamycin in mice by Dodds, Sherry G., Livi, Carolina B., Parihar, Manish, Hsu, Hang-Kai, Benavides, Adriana D., Morris, Jay, Javors, Martin, Strong, Randy, Christy, Barbara, Hasty, Paul, Sharp, Zelton Dave

    “…Rapamycin inhibits mechanistic (or mammalian) target of rapamycin (mTOR) that promotes protein production in cells by facilitating ribosome biogenesis (RiBi)…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Abstract 671: mTORC1 suppression in Paneth cells prevents tumors in a mouse model of intestinal cancer by Parihar, Manish, Dodds, Sherry G., Hasty, Paul, Sharp, Zelton Dave

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract The mechanistic (or mammalian) target of rapamycin, mTOR, is a highly conserved PI3K-related kinase that regulates cell growth, proliferation,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    mTORC1 and p53: Clash of the gods? by Hasty, Paul, Sharp, Zelton Dave, Curiel, Tyler J., Campisi, Judith

    Published in Cell cycle (Georgetown, Tex.) (01-01-2013)
    “…A balance must be struck between cell growth and stress responses to ensure that cells proliferate without accumulating damaged DNA. This balance means that…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Aging and TOR: interwoven in the fabric of life by Sharp, Zelton Dave

    “…Longstanding results with calorie and growth factor restriction plus recent results with the first interventional drug suggest that retarding the pace of aging…”
    Get full text
    Journal Article
  19. 19

    Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model by Parihar, Manish, Dodds, Sherry G., Hubbard, Gene, Javors, Martin A., Strong, Randy, Hasty, Paul, Sharp, Zelton Dave

    Published in Clinical colorectal cancer (01-03-2021)
    “…We previously showed that lifelong rapamycin treatment of short-lived ApcMin/+ mice, a model for familial adenomatous polyposis, resulted in a normal lifespan…”
    Get full text
    Journal Article
  20. 20

    Rapamycin extends life span of Rb1+/- mice by inhibiting neuroendocrine tumors by Livi, Carolina B, Hardman, Rulon L, Christy, Barbara A, Dodds, Sherry G, Jones, Diane, Williams, Charnae, Strong, Randy, Bokov, Alex, Javors, Martin A, Ikeno, Yuji, Hubbard, Gene, Hasty, Paul, Sharp, Zelton Dave

    Published in Aging (Albany, NY.) (01-02-2013)
    “…Chronic treatment of mice with an enterically released formulation of rapamycin (eRapa) extends median and maximum life span, partly by attenuating cancer. The…”
    Get full text
    Journal Article